Will the combo drug succeed?
Clinical trial of a combination vaccine against AIDS has begun in India. The Indian Council of Medical Research, the body governing biomedical research in India, is selecting volunteers for the trial. ADVAX and tbc-m 4 vaccines have been tested individually and now the researchers are trying to see if they work better in tandem through the prime boost method. In this method, one vaccine is combined with another to boost the effect of the first vaccine. Previous trials of aids vaccines have been controversial. In 2005, an aids vaccine that had failed in Europe, was tried in India.
The current trial is being carried out in collaboration with the International aids Vaccine Initiative at the National aids Research Institute, Pune, and Tuberculosis Research Centre, Chennai.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.